Related Experiment Videos
Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma
1Pulmonary Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Abstract:
To investigate the specific transduction of a suicide gene into human small cell lung carcinoma (SCLC) cells, we explored the promoter region of the neuron specific enolase (NSE) gene as a tumor-specific promoter. In Northern blot analysis, NSE mRNA was expressed more abundantly in the SBC3 human SCLC cell line than in the RERF human SCLC cell line, the A549 human lung adenocarcinoma cell line and the HeLa human uterine cervix epitheloid carcinoma cell line. A reporting vector containing the NSE promoter (pNSE-LUC) exhibited higher luciferase activity in SBC3 than in the other three cell lines. After transfecting an expression vector containing the NSE promoter-bound HSV-TK gene (pNSE-TK) into the cells, we measured their sensitivity to ganciclovir (GCV). In SBC3, pNSE-TK transfected cells showed about the same sensitivity to GCV as non-transfected (parental) cells. Though the NSE promoter itself is not optimal for use in suicide gene transfer to SCLC cells, it might be applied as a tumor-specific promoter after enhancement of its activity.
Insights
Researchers explored the neuron-specific enolase (NSE) promoter for small cell lung cancer (SCLC) gene therapy. While NSE showed tumor-specific expression, its activity requires enhancement for effective suicide gene transfer in SCLC.
Area of Science:
- Molecular Biology
- Oncology
- Gene Therapy
Background:
- Small cell lung carcinoma (SCLC) requires targeted therapeutic strategies.
- Tumor-specific promoters are crucial for directing suicide gene therapy to cancer cells.
- The neuron-specific enolase (NSE) gene promoter is a candidate for SCLC targeting.
Purpose of the Study:
- To evaluate the neuron-specific enolase (NSE) promoter for specific transduction of suicide genes into human SCLC cells.
- To assess the potential of the NSE promoter in driving gene expression within SCLC cell lines.
Main Methods:
- Northern blot analysis was used to detect NSE mRNA expression in various human cancer cell lines (SBC3, RERF, A549, HeLa).
- A reporter vector (pNSE-LUC) containing the NSE promoter was transfected to measure luciferase activity.
- An expression vector (pNSE-TK) with the HSV-TK gene under the NSE promoter was introduced into SCLC cells to assess ganciclovir (GCV) sensitivity.
Main Results:
- NSE mRNA was expressed more abundantly in SBC3 SCLC cells compared to other cell lines.
- The NSE promoter exhibited higher luciferase activity in SBC3 cells.
- Transfection of pNSE-TK into SBC3 cells did not significantly alter their sensitivity to ganciclovir (GCV).
Conclusions:
- The neuron-specific enolase (NSE) promoter demonstrates tumor-specific expression in SCLC cells.
- The intrinsic activity of the NSE promoter is not optimal for direct suicide gene transfer in SCLC.
- Enhancement of NSE promoter activity may enable its effective application in SCLC-targeted suicide gene therapy.